Literature DB >> 23407655

Rapid and automated multidimensional fluorescence microscopy profiling of 3D human breast cultures.

Catherine C Park1, Walter Georgescu, Aris Polyzos, Christopher Pham, Kazi M Ahmed, Hui Zhang, Sylvain V Costes.   

Abstract

Three-dimensional (3D) tissue culture provides a physiologically relevant microenvironment for distinguishing malignant from non-malignant breast cell phenotypes. 3D culture assays can also be used to test novel cancer therapies and predict a differential response to radiation between normal and malignant cells in vivo. However, biological measurements in such complex models are difficult to quantify and current approaches do not allow for in-depth multifaceted assessment of individual colonies or unique sub-populations within the entire culture. This is in part due to the limitations of imaging at a range of depths in 3D culture resulting from optical aberrations and intensity attenuation. Here, we address these limitations by combining sample smearing techniques with high-throughput 2D imaging algorithms to accurately and rapidly quantify imaging features acquired from 3D cultures. Multiple high resolution imaging features especially designed to characterize 3D cultures show that non-malignant human breast cells surviving large doses of ionizing radiation acquire a "swelled acinar" phenotype with fewer and larger nuclei, loss of cell connectivity and diffused basement membrane. When integrating these imaging features into hierarchical clustering classification, we could also identify subpopulations of phenotypes from individual human tumor colonies treated with ionizing radiation or/and integrin inhibitors. Such tools have therefore the potential to further characterize cell culture populations after cancer treatment and identify novel phenotypes of resistance.

Entities:  

Mesh:

Year:  2013        PMID: 23407655      PMCID: PMC3641787          DOI: 10.1039/c3ib20275e

Source DB:  PubMed          Journal:  Integr Biol (Camb)        ISSN: 1757-9694            Impact factor:   2.192


  31 in total

1.  Quantitative image analysis of laminin immunoreactivity in skin basement membrane irradiated with 1 GeV/nucleon iron particles.

Authors:  S Costes; C H Streuli; M H Barcellos-Hoff
Journal:  Radiat Res       Date:  2000-10       Impact factor: 2.841

2.  Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures.

Authors:  Jayanta Debnath; Senthil K Muthuswamy; Joan S Brugge
Journal:  Methods       Date:  2003-07       Impact factor: 3.608

3.  [Biomedical image analysis by mathematical morphology (author's transl)].

Authors:  J Serra
Journal:  Pathol Biol (Paris)       Date:  1979-04

4.  Fibronectin alters cell survival and intracellular signaling of confluent A549 cultures after irradiation.

Authors:  N Cordes; C Beinke
Journal:  Cancer Biol Ther       Date:  2004-01-25       Impact factor: 4.742

5.  Ionizing radiation induces heritable disruption of epithelial cell interactions.

Authors:  Catherine C Park; Rhonda L Henshall-Powell; Anna C Erickson; Rabih Talhouk; Bahram Parvin; Mina J Bissell; Mary Helen Barcellos-Hoff
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-05       Impact factor: 11.205

6.  Fibronectin and laminin increase resistance to ionizing radiation and the cytotoxic drug Ukrain in human tumour and normal cells in vitro.

Authors:  N Cordes; M A Blaese; L Plasswilm; H P Rodemann; D Van Beuningen
Journal:  Int J Radiat Biol       Date:  2003-09       Impact factor: 2.694

7.  To create the correct microenvironment: three-dimensional heterotypic collagen assays for human breast epithelial morphogenesis and neoplasia.

Authors:  Thorarinn Gudjonsson; Lone Rønnov-Jessen; René Villadsen; Mina J Bissell; Ole William Petersen
Journal:  Methods       Date:  2003-07       Impact factor: 3.608

8.  Functional differentiation and alveolar morphogenesis of primary mammary cultures on reconstituted basement membrane.

Authors:  M H Barcellos-Hoff; J Aggeler; T G Ram; M J Bissell
Journal:  Development       Date:  1989-02       Impact factor: 6.868

9.  β1 integrin mediates an alternative survival pathway in breast cancer cells resistant to lapatinib.

Authors:  Catherine Huang; Catherine C Park; Susan G Hilsenbeck; Robin Ward; Mothaffar F Rimawi; Yen-Chao Wang; Jiang Shou; Mina J Bissell; C Kent Osborne; Rachel Schiff
Journal:  Breast Cancer Res       Date:  2011-08-31       Impact factor: 6.466

10.  Cellular growth and survival are mediated by beta 1 integrins in normal human breast epithelium but not in breast carcinoma.

Authors:  A R Howlett; N Bailey; C Damsky; O W Petersen; M J Bissell
Journal:  J Cell Sci       Date:  1995-05       Impact factor: 5.285

View more
  4 in total

1.  Multilayered, Hyaluronic Acid-Based Hydrogel Formulations Suitable for Automated 3D High Throughput Drug Screening of Cancer-Stromal Cell Cocultures.

Authors:  Brian J Engel; Pamela E Constantinou; Lindsey K Sablatura; Nathaniel J Doty; Daniel D Carson; Mary C Farach-Carson; Daniel A Harrington; Thomas I Zarembinski
Journal:  Adv Healthc Mater       Date:  2015-06-09       Impact factor: 9.933

2.  β1-Integrin via NF-κB signaling is essential for acquisition of invasiveness in a model of radiation treated in situ breast cancer.

Authors:  Jin-Min Nam; Kazi M Ahmed; Sylvain Costes; Hui Zhang; Yasuhito Onodera; Adam B Olshen; Kanako C Hatanaka; Rumiko Kinoshita; Masayori Ishikawa; Hisataka Sabe; Hiroki Shirato; Catherine C Park
Journal:  Breast Cancer Res       Date:  2013       Impact factor: 6.466

3.  Evaluation of Nanoparticle Penetration in the Tumor Spheroid Using Two-Photon Microscopy.

Authors:  Feby Wijaya Pratiwi; Chien-Chung Peng; Si-Han Wu; Chiung Wen Kuo; Chung-Yuan Mou; Yi-Chung Tung; Peilin Chen
Journal:  Biomedicines       Date:  2020-12-24

4.  Novel approach for quantification of multiple immunofluorescent signals using histograms and 2D plot profiling of whole-section panoramic images.

Authors:  Roko Duplancic; Darko Kero
Journal:  Sci Rep       Date:  2021-04-21       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.